Synthesis and in vitro characterization of platinum(II) anticancer coordinates using FTIR spectroscopy and NCI COMPARE: A fast method for new compound discovery

Bioorganic and Medicinal Chemistry

Volumn 22, Issue 13, 2014, Pages 3527-3536

  Berger, Gilles ^a   Leclercqz, Hélène ^a   Derenne, Allison ^a   Gelbcke, Michel ^a   Goormaghtigh, Erik ^a   Nève, Jean ^a   Mathieu, Véronique ^a   Dufrasne, François ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Chemotherapy; COMPARE; Cytotoxicity; Infrared spectroscopy; NCI; Platinum

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; NSC 614887; NSC 625299; NSC 635450; NSC 691081; NSC 692758; NSC 765877; OXALIPLATIN; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG; PLATINUM COMPLEX;

ALGORITHM; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG DEVELOPMENT; DRUG EFFECTS; FLOW CYTOMETRY; INFRARED SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; MOLECULAR STRUCTURE; ORGANOPLATINUM COMPOUNDS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84901944910     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2014.04.017     Document Type: Article

References (65)

1. B. Rosenberg, L. Van Camp, and T. Krigas Nature 205 1965 698
2. P.J. Loehrer, and L.H. Einhorn Ann. Intern. Med. 100 1984 704
3. J.P. Neijt, W.W. ten Bokkel Huinink, M.E.L. van der Burg, A.T. van Oosterom, P.H.B. Willemse, J.B. Vermorken, A.C.M. van Lindert, A.P.M. Heintz, E. Aartsen, M. van Lent, J.B. Trimbos, and A.J. de Meijer Eur. J. Cancer 11 1991 1637
4. B. Lippert Cisplatin Chemistry and Biochemistry of a Leading Anticancer Drug 1995 VCHA & Wiley-VCH
5. L.R. Kelland, and N.P. Farrel Platinum-based Drugs in Cancer Therapy 2010 Humana Press
6. K. Wang, and E. Enjun Anticancer Agents Med. Chem. 14 2014 147
7. T.C. Johnstone, J.J. Wilson, and S.J. Lippard Inorg. Chem. 52 2013 12234
8. C.F. Chin, Q. Tian, M.I. Setyawati, W. Fang, E.S.Q. Tan, and D.T. Leong et al. J. Med. Chem. 55 2012 7571
9. E. Wong, and C.M. Giandomenico Chem. Rev. 99 1999 2451
10. M. Galanski, M.A. Jakupec, and B.K. Keppler Curr. Med. Chem. 12 2005 2075
11. K.S. Lovejoy, and S.J. Lippard Dalton Trans. 48 2009 10651
12. N.J. Wheate, S. Walker, G.E. Craig, and R. Oun Dalton Trans. 39 2010 8113
13. I. Würtenberger, B. Angermaier, B. Kircher, and R. Gust J. Med. Chem. 56 2013 7951
14. D. Helm, H. Labischinski, G. Schallen, and D. Naumann J. Gen. Microbiol. 137 1991 69
15. A. Derenne, V. Van Hemelryck, D. Lamoral-Theys, R. Kiss, and E. Goormaghtigh Biochim. Biophys. Acta 46 2012 1832
16. G. Berger, R. Gasper, D. Lamoral-theys, A. Wellner, M. Gelbcke, and R. Gust et al. Int. J. Oncol. 37 2010 679
17. V.M. Gonzalez, M.A. Fuertes, C. Alonso, and J.M. Perez Mol. Pharmacol. 59 2001 657
18. K.R. Flower, I. Khalifa, P. Bassan, D. Demoulin, E. Jackson, N.P. Lockyer, A.T. McGown, P. Miles, L. Vaccari, and P. Gardner Analyst 136 2011 498
19. A. Derenne, R. Gasper, and E. Goormaghtigh Analyst 136 2011 1134
20. A. Derenne, M. Verdonck, and E. Goormaghtigh Analyst 137 2012 3255
21. F. Dufrasne, M. Gelbcke, B. Schnurr, and R. Gust Arch. Pharm. 335 2002 229
22. A. Dullin, F. Dufrasne, M. Gelbcke, and R. Gust Arch. Pharm. 337 2004 654
23. A. Dullin, F. Dufrasne, M. Gelbcke, and R. Gust ChemMedChem 1 2006 644
24. W.J.F. Van der Vijgh Clin. Pharmacokinet. 21 1991 242
25. G. Berger, M. Gelbcke, E. Cauët, M. Luhmer, J. Nève, and F. Dufrasne Tetrahedron Lett. 54 2012 545
26. M.T. Reetz, W.M. Drewes, A. Schmitz, X. Holdgrün, T. Wünsch, and J. Binder Philos. Trans. R. Soc. 326 1988 573
27. G. Berger Comput. Theor. Chem. 1010 2013 11
28. P. Jordan, and M. Carmo-Fonseca Cell. Mol. Life Sci. 57 2000 1229
29. M. Akaboshi, K. Kawai, H. Maki, K. Akuta, Y. Ujeno, and T. Miyahara Jpn. J. Cancer Res. 83 1992 522
30. M. Akaboshi, K. Kawai, Y. Ujeno, S. Takada, and T. Miyahara Jpn. J. Cancer Res. 85 1994 106
31. P. Lasch, A. Pacifico, and M. Diem Biopolymers 67 2002 335
32. M. Diem, S. Boydston-White, and L. Chiriboga Appl. Spectrosc. 53 1999 148A
33. J.H. Ward J. Am. Stat. Assoc. 58 1963 236
34. Developmental Therapeutic Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, U.S. (http://dtp.cancer. gov).
35. M.C. Alley, D.A. Scudiero, A. Monks, M.L. Hursey, M.J. Czerwinski, and D.L. Fine et al. Cancer Res. 48 1988 589
36. R.H. Shoemaker Nat. Rev. Cancer 6 2006 813
37. K.D. Paull, R.H. Shoemaker, L. Hodes, A. Monks, D.A. Scudiero, L. Rubinstein, J. Plowman, and M.R. Boyd J. Natl Cancer Inst. 81 1989 1088
38. R. Bai, K.D. Paull, C.L. Herald, G.R. Pettit, and E. Hamel J. Biol. Chem. 266 1991 15882
39. K.D. Paull, C.M. Lin, L. Malspeis, and E. Hamel Cancer Res. 52 1992 3892
40. L. Hodes, K.D. Paull, A. Koutsoukos, and L.R. Rubinstein J. Biopharm. Stat. 2 1992 31
41. L. Kelland Nat. Rev. Cancer 7 2007 573
42. H.P. Varbanov, M.a. Jakupec, A. Roller, F. Jensen, M. Galanski, and B.K. Keppler J. Med. Chem. 56 2013 330
43. E. Monti, M. Gariboldi, A. Maiocchi, E. Marengo, C. Cassino, E. Gabano, and D. Osella J. Med. Chem. 48 2005 857
44. S. Hector, W. Bolanowska-Higdon, J. Zdanowicz, S. Hitt, and L. Pendyala Cancer Chemother. Pharmacol. 48 2001 398
45. I. Judson, and L.R. Kelland Drugs 59 2000 29
46. D.P. Bancroft, C.A. Lepre, and S.J. Lippard J. Am. Chem. Soc. 112 1990 6860
47. M. Howe-Grant, and S.J. Lippard Met. Ions Biol. Syst. 11 1980 63
48. B. Rosenberg Met. Ions Biol. Syst. 11 1980 127
49. C. Zhang, H. Liu, Q. Yang, J. Chang, and X. Sun Chin. J. Chem. 31 2013 154
50. O. Rixe, W. Ortuzar, M. Alvarez, R. Parker, E. Reed, K. Paull, and T. Fojo Biochem. Pharmacol. 52 1996 1855
51. J.P. Scovill, D.L. Klayman, and C.F. Franchino J. Med. Chem. 25 1982 1261
52. F. Tisato, C. Marzano, M. Porchia, M. Pellei, and C. Santini Med. Res. Rev. 30 2010 708
53. N. Saban, and M. Bujak Cancer Chemother. Pharmacol. 64 2009 213
54. J.G. Park, B.S. Kramer, S.M. Steinberg, J. Carmichael, J.M. Collins, J.D. Minna, and A.F. Gazdar Cancer Res. 47 1987 5875
55. J. Carmichael, J.B. Mitchell, W.G. De Graff, J. Gamson, A.F. Gazdar, B.E. Johnson, E. Glatstein, and J.D. Minna Br. J. Cancer 57 1988 540
56. J. Pontén, and E.H. Macintyre Acta Pathol. Microbiol. Scand. A 74 1968 465
57. R.B. Owens, H.S. Smith, W.A. Nelson-Rees, and E.L. Springer J. Natl Cancer Inst. 56 1976 843
58. D.J. Giard, S.A. Aaronson, G.J. Todaro, P. Arnstein, J.H. Kersey, H. Dosik, and W.P. Parks J. Natl Cancer Inst. 51 1973 1417
59. J.C. Rockett, K. Larkin, S.J. Darnton, A.G. Morris, and H.R. Matthews Br. J. Cancer 258 1997 258
60. J. Fogh, J.M. Fogh, and T. Orfeo J. Natl Cancer Inst. 59 1977 221
61. I.J. Fidler Cancer Res. 35 1975 218
62. T. Mosmann J. Immunol. Methods 65 1983 55
63. R. Gasper, and E. Goormaghtigh Analyst 135 2010 3048
64. Goormaghtigh, E. FTIR Data Processing and Analysis Tools, In: Barth, A., Haris, P. I. (Eds.), Adv. Biomed. Spectrosc., Vol. 2, 2009, pp 104-128.
65. E. Goormaghtigh, and J. Ruysschaert Spectrochim. Acta 50 1994 2137